Biltmore Family Office LLC Lowers Stock Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Biltmore Family Office LLC decreased its stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 5.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,160 shares of the exchange traded fund’s stock after selling 996 shares during the quarter. Biltmore Family Office LLC’s holdings in SPDR S&P Biotech ETF were worth $1,635,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Golden State Wealth Management LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 4th quarter worth approximately $29,000. Kohmann Bosshard Financial Services LLC purchased a new position in shares of SPDR S&P Biotech ETF in the 4th quarter worth approximately $29,000. Avior Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 393.6% during the fourth quarter. Avior Wealth Management LLC now owns 385 shares of the exchange traded fund’s stock worth $35,000 after purchasing an additional 307 shares in the last quarter. Lee Danner & Bass Inc. acquired a new position in SPDR S&P Biotech ETF during the 4th quarter valued at about $38,000. Finally, Bank of Jackson Hole Trust acquired a new position in shares of SPDR S&P Biotech ETF during the fourth quarter valued at about $43,000.

SPDR S&P Biotech ETF Price Performance

Shares of XBI stock opened at $80.59 on Thursday. SPDR S&P Biotech ETF has a 1 year low of $77.26 and a 1 year high of $105.47. The firm has a market capitalization of $5.08 billion, a price-to-earnings ratio of 11.47 and a beta of 1.00. The business has a fifty day moving average of $88.81 and a 200 day moving average of $93.53.

SPDR S&P Biotech ETF Cuts Dividend

The company also recently announced a dividend, which was paid on Wednesday, March 26th. Stockholders of record on Monday, March 24th were paid a dividend of $0.0053 per share. The ex-dividend date of this dividend was Monday, March 24th.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.